Page 9 - SDIR5 Abstract book 21 12 2021.
P. 9
13.52 – 13.59 Jelena Stanić. Radiation-induced lymphocyte apoptosis as a possible biological
predictor of radiotherapy toxicity in prostate cancer patients. Institute of
Oncology and Radiology of Serbia, Serbia
13.59 – 14.06 Aleksandar Stepanović. Can miRNA expression patterns predict radiotoxicity in
patients with glioblastoma? Institute of Oncology and Radiology of Serbia, Serbia
14.06 – 14.13 Bojana Kožik. Potential predictive role of K-ras gene mutation and BCL2 protein
expression status in locally advanced rectal cancers treated with neoadjuvant
chemoradiotherapy. Vinča Institute of Nuclear Sciences, National Institute of
Republic of Serbia, University of Belgrade, Serbia
14.13 – 14.30 Discussion
14.30 – 15.15 Poster Session, lunch break and industry session viewing.
Moderator Ana Krivokuća
15.15 – 17.00 Session: Imaging in cancer
Chair: Jelena Grahovac
15.15 – 15.35 Bojana Gligorijević. Real-time microscopy of invasive cancer cells in the tumor
microenvironment context. Temple University, USA
15.35 – 15.55 Jelena Stanisavljević. Defining and imaging colon cancer heterogeneity. Institute
of Photonic Sciences, Barcelona Institute for Science and Technology, Spain
15.55 – 16.15 Giorgio Seano. Vessel co-option and resistance to therapy in glioblastoma.
Institut Curie Research Center, Centre Universitaire, France
16.15 – 16.43 Short talks selected from abstracts
16.15 – 16.22 Predrag Jovanovic. Characterizing the role of 4E-BP1 in breast cancer metastasis.
Jewish General Hospital, Lady Davis Institute, Montreal, Canada; McGill
University, Experimental Medicine, Montreal, Canada
16.22 – 16.29 F. Koutsougianni. Siramesine, a non-opioid σ2 receptor agonist as a potential
agent for the development of novel targeted treatments for pancreatic cancer.
University of Thessaly, Larisa, Greece
16.29 – 16.36 Batuhan Mert Kalkan. The role of Nek2 on centrosome clustering in cancer cells
with extra centrosomes. Koç University, Graduate School of Health Sciences,
Istanbul, Turkey
16.36 – 16.43 Tijana Martinov. Sox2-targeted T cell therapy for treating multiple myeloma.
Fred Hutchinson Cancer Research Center, Seattle, United States of America
16.43 – 17.00 Discussion
17.00 – 17.30 Closing remarks and best poster awards. SDIR President Mirjana
Branković-Magić
III
SDIR – 5
